Quantcast

Latest Cancer Research Stories

2014-06-17 23:03:04

New research study “Antibiotics Partnering Terms and Agreements” worked out by CurrentPartnering is now available at MarketPublishers.com. London, UK (PRWEB) June 17, 2014 Antibiotics are antimicrobial compounds, used to treat a broad range of various bacterial infections in humans as well as animals and plants. Antibiotics have saved countess lives since their discovery. Antibiotics are effective against certain fungal and bacterial infections and are also used a treatment for...

2014-06-17 11:02:54

Ohio State University Giving low doses of a particular targeted agent with a cancer-killing virus might improve the effectiveness of the virus as a treatment for cancer, according to a study led by researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). Viruses that are designed to kill cancer cells – oncolytic viruses – have shown promise in clinical trials for the...

2014-06-17 08:29:05

Side-By-Side Genomic Analysis of Patients' Tumor and TumorGraft Mouse Avatars Before and After Treatment Also to be Conducted NEW YORK and HACKENSACK, N.J., June 17, 2014 /PRNewswire/ -- Icahn School of Medicine at Mount Sinai and Champions Oncology (OTC: CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced the initiation of a clinical trial evaluating the use of Champions...

2014-06-17 08:28:03

Nearly 500 Pancreatic Cancer Advocates Head to Capitol Hill Today MANHATTAN BEACH, Calif., June 17, 2014 /PRNewswire/ -- Nearly 500 people from across the country are on Capitol Hill today for the eighth annual Pancreatic Cancer Advocacy Day urging Congress to stomp on pancreatic cancer by stepping up federal research funding. Advocates from the Pancreatic Cancer Action Network will call on Congress to provide $5.26 billion for the National Cancer Institute (NCI) for FY15 and...

2014-06-16 23:02:03

Teams supporting Children's Cancer Research Fund have raised $1.5 million for lifesaving research and treatment. Saint Paul, Minn. (PRWEB) June 16, 2014 Nearly 100 teams comprised of pediatric cancer survivors, their families, competitive runners and recreational walkers will join the race against childhood cancer at Time to Fly 2014, presented by Winnesota Regional Transportation, on Saturday, June 21. These teams of runners and walkers will wear special t-shirts, buttons or signs...

2014-06-16 16:25:14

Lung-MAP Trial Will Test Five Investigational Approaches, Including Amgen's Rilotumumab, an Investigational Fully Human Monoclonal Antibody THOUSAND OAKS, Calif., June 16, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) announced today that it will collaborate with the National Cancer Institute (NCI), part of the National Institutes of Health, and other public and private sector partners on the Lung Master Protocol (Lung-MAP), a groundbreaking new clinical trial program that will use...

2014-06-16 08:29:32

The Lung-MAP trial uses a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles BETHESDA, Md., June 16, 2014 /PRNewswire/ -- A unique public-private collaboration among the National Cancer Institute (NCI), part of the National Institutes of Health, SWOG Cancer Research, Friends of Cancer Research (Friends), the Foundation for the National Institutes of Health (FNIH), five pharmaceutical companies (Amgen,...

2014-06-13 08:24:14

Research grant recipient will be studying the contribution of the polycomb repressive complex (PRC2) towards gastric cancer progression. FT. LAUDERDALE, Fla., June 13, 2014 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF), a non-profit organization that raises awareness and funds for stomach cancer, launched its first research grant of $50,000 for a Young Fellowship Award. The organization presented Dr. David Allison with the fellowship on April 5, 2014 at the...

2014-06-11 08:30:00

FLEMINGTON, N.J., June 11, 2014 /PRNewswire/ -- According to the American Cancer Society, lung cancer is the second most common cancer among men and women and the leading cause of death in the United States. In 2014, it is estimated that 224,210 people will be diagnosed with lung cancer. Hunterdon Regional Cancer Center was selected as the only cancer facility in New Jersey to offer a clinical study on a new investigational lung cancer drug called Nivolumab, developed by Bristol-Myers...

2014-06-10 08:30:28

POINT ROBERTS, Wash. and NEW YORK, June 10, 2014 /PRNewswire/ -- Investorideas.com, a global news source covering leading sectors including biotech and medical technology issues a Q&A interview with Mr. James A. Joyce ,Chairman and CEO of Aethlon Medical, Inc. (OTCBB: AEMD). Mr. Joyce shares insight into the emerging Immuno-Oncology market and the opportunity it represents. Q: Investorideas.com How did Aethlon Medical become involved in cancer research? A: James A. Joyce,...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related